ASBP
Price
$0.35
Change
+$0.02 (+6.06%)
Updated
Jul 10 closing price
Capitalization
N/A
ORIC
Price
$11.45
Change
+$0.55 (+5.05%)
Updated
Jul 10 closing price
Capitalization
928.88M
27 days until earnings call
Interact to see
Advertisement

ASBP vs ORIC

Header iconASBP vs ORIC Comparison
Open Charts ASBP vs ORICBanner chart's image
Aspire Biopharma Holdings
Price$0.35
Change+$0.02 (+6.06%)
Volume$7.14M
CapitalizationN/A
Oric Pharmaceuticals
Price$11.45
Change+$0.55 (+5.05%)
Volume$905.51K
Capitalization928.88M
ASBP vs ORIC Comparison Chart in %
Loading...
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASBP vs. ORIC commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASBP is a Hold and ORIC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (ASBP: $0.35 vs. ORIC: $11.45)
Brand notoriety: ASBP and ORIC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASBP: 95% vs. ORIC: 67%
Market capitalization -- ASBP: $0 vs. ORIC: $928.88M
ASBP [@Biotechnology] is valued at $0. ORIC’s [@Biotechnology] market capitalization is $928.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASBP’s FA Score shows that 1 FA rating(s) are green whileORIC’s FA Score has 0 green FA rating(s).

  • ASBP’s FA Score: 1 green, 4 red.
  • ORIC’s FA Score: 0 green, 5 red.
According to our system of comparison, ORIC is a better buy in the long-term than ASBP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASBP’s TA Score shows that 5 TA indicator(s) are bullish while ORIC’s TA Score has 2 bullish TA indicator(s).

  • ASBP’s TA Score: 5 bullish, 2 bearish.
  • ORIC’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ASBP is a better buy in the short-term than ORIC.

Price Growth

ASBP (@Biotechnology) experienced а +18.60% price change this week, while ORIC (@Biotechnology) price change was +6.02% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +10.19%. For the same industry, the average monthly price growth was +16.32%, and the average quarterly price growth was +20.67%.

Reported Earning Dates

ASBP is expected to report earnings on May 14, 2025.

ORIC is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+10.19% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORIC YTD gains are higher at: 41.884 vs. ASBP (-96.989).
ASBPORICASBP / ORIC
CapitalizationN/A929M-
EBITDAN/A-145.48M-
Gain YTD-96.98941.884-232%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A204M-
Total DebtN/A3.21M-
TECHNICAL ANALYSIS
Technical Analysis
ASBPORIC
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
42%
Bearish Trend 1 day ago
89%
Momentum
ODDS (%)
Bullish Trend 1 day ago
34%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
31%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
34%
Bullish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
35%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 1 day ago
36%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
20%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
ASBP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA309.8713.99
+4.73%
Tesla
BTC.X115987.2000004660.648400
+4.19%
Bitcoin cryptocurrency
AAPL212.411.27
+0.60%
Apple
SPY625.821.76
+0.28%
SPDR® S&P 500® ETF
GME23.10-0.09
-0.39%
GameStop Corp

ASBP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASBP has been loosely correlated with SPRO. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ASBP jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASBP
1D Price
Change %
ASBP100%
+6.23%
SPRO - ASBP
58%
Loosely correlated
-6.58%
ALZN - ASBP
28%
Poorly correlated
-0.33%
ORIC - ASBP
28%
Poorly correlated
+5.05%
ERAS - ASBP
28%
Poorly correlated
-1.30%
BRNS - ASBP
28%
Poorly correlated
N/A
More

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with ERAS. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
+5.05%
ERAS - ORIC
50%
Loosely correlated
-1.30%
ROIV - ORIC
48%
Loosely correlated
+3.12%
ATXS - ORIC
48%
Loosely correlated
-1.48%
KYMR - ORIC
48%
Loosely correlated
+0.07%
ETNB - ORIC
46%
Loosely correlated
+2.04%
More